Shu-Ching Hu - Publications

Affiliations: 
University of Washington, Seattle, Seattle, WA 

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Costa-Mallen P, Zabetian CP, Hu SC, Agarwal P, Yearout D, Checkoway H. Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 27349967 DOI: 10.1007/s00702-016-1590-x  0.6
2016 Mata IF, Davis MY, Lopez AN, Dorschner MO, Martinez E, Yearout D, Cholerton BA, Hu SC, Edwards KL, Bird TD, Zabetian CP. The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 27111571 DOI: 10.1002/ajmg.b.32452  0.6
2016 Hossein-Nezhad A, Fatemi RP, Ahmad R, Peskind E, Zabeitian C, Hu SC, Shi M, Wahlestedt C, Zhang J, Faghihi MA. Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Diseases. Journal of Parkinson's Disease. PMID 26889637 DOI: 10.3233/JPD-150737  0.6
2015 Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, ... ... Hu SC, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Molecular Neurodegeneration. 10: 50. PMID 26399558 DOI: 10.1186/s13024-015-0045-4  0.6
2015 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, ... ... Hu SC, et al. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26296077 DOI: 10.1002/mds.26359  0.6
2015 Costa-Mallen P, Zabetian CP, Agarwal P, Hu SC, Yearout D, Samii A, Leverenz JB, Roberts JW, Checkoway H. Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk. Parkinsonism & Related Disorders. 21: 1087-92. PMID 26228081 DOI: 10.1016/j.parkreldis.2015.07.006  0.6
2015 Yang Y, Keene CD, Peskind ER, Galasko DR, Hu SC, Cudaback E, Wilson AM, Li G, Yu CE, Montine KS, Zhang J, Baird GS, Hyman BT, Montine TJ. Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. Journal of Neuropathology and Experimental Neurology. 74: 672-87. PMID 26083568 DOI: 10.1097/NEN.0000000000000207  0.6
2015 Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, ... ... Hu SC, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/mds.26161  0.6
2015 Shi M, Movius J, Dator R, Aro P, Zhao Y, Pan C, Lin X, Bammler TK, Stewart T, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Zhang J. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation. Molecular & Cellular Proteomics : McP. 14: 544-55. PMID 25556233 DOI: 10.1074/mcp.M114.040576  0.6
2014 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, ... ... Hu SC, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. Jama Neurology. 71: 1405-12. PMID 25178429 DOI: 10.1001/jamaneurol.2014.1455  0.6
2014 Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathologica. 128: 639-50. PMID 24997849 DOI: 10.1007/s00401-014-1314-y  0.6
2014 Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL. Evaluation of mild cognitive impairment subtypes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 756-64. PMID 24710804 DOI: 10.1002/mds.25875  0.6
2014 Ton TG, Biggs ML, Comer D, Curtis L, Hu SC, Thacker EL, Searles Nielsen S, Delaney JA, Landsittel D, Longstreth WT, Checkoway H, Jain S. Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study. Pharmacoepidemiology and Drug Safety. 23: 119-27. PMID 24357102 DOI: 10.1002/pds.3552  0.6
2013 Cholerton BA, Zabetian CP, Quinn JF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Edwards KL, Montine TJ, Leverenz JB. Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics. Journal of Parkinson's Disease. 3: 205-14. PMID 23938350 DOI: 10.3233/JPD-130189  0.6
2012 Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/srep00954  0.6
2012 Hu SC, Hebb AO. Effect of deep brain stimulation on postencephalitic parkinsonism: a case report. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1071-2. PMID 22555963 DOI: 10.1002/mds.25014  0.6
2008 Merchant KM, Chesselet MF, Hu SC, Fahn S. Animal models of parkinson's disease to aid drug discovery and development Animal and Translational Models For Cns Drug Discovery. 2: 159-205. DOI: 10.1016/B978-0-12-373861-5.00017-5  0.6
2008 Hu SC, Frucht SJ, Shibasaki H. Myoclonus Therapeutics of Parkinson's Disease and Other Movement Disorders. 363-370. DOI: 10.1002/9780470713990.ch24  0.6
2007 Hu SC, Frucht SJ. Emergency treatment of movement disorders. Current Treatment Options in Neurology. 9: 103-14. PMID 17298771 DOI: 10.1007/s11940-007-0036-z  0.6
2006 Ince-Dunn G, Hall BJ, Hu SC, Ripley B, Huganir RL, Olson JM, Tapscott SJ, Ghosh A. Regulation of thalamocortical patterning and synaptic maturation by NeuroD2. Neuron. 49: 683-95. PMID 16504944 DOI: 10.1016/j.neuron.2006.01.031  0.6
2005 Walker M, Meekins G, Hu SC. Yoga neuropathy. A snoozer. The Neurologist. 11: 176-8. PMID 15860140 DOI: 10.1097/01.nrl.0000159986.75426.d5  0.6
2004 Aizawa H, Hu SC, Bobb K, Balakrishnan K, Ince G, Gurevich I, Cowan M, Ghosh A. Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. Science (New York, N.Y.). 303: 197-202. PMID 14716005 DOI: 10.1126/science.1089845  0.6
2004 Hu S, Walker M, Czartoski T, Cheng A, Forghani B, Gilden DH, Garden GA. Acyclovir responsive brain stem disease after the Ramsay Hunt syndrome Journal of the Neurological Sciences. 217: 111-113. PMID 14675618 DOI: 10.1016/j.jns.2003.08.011  0.6
1999 Hu SC, Chrivia J, Ghosh A. Regulation of CBP-mediated transcription by neuronal calcium signaling. Neuron. 22: 799-808. PMID 10230799 DOI: 10.1016/S0896-6273(00)80738-2  0.6
1998 Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron. 20: 727-40. PMID 9581764 DOI: 10.1016/S0896-6273(00)81011-9  0.6
1997 Tu YK, Liu HM, Hu SC. Direct surgery of carotid cavernous fistulae and dural arteriovenous malformations of the cavernous sinus. Neurosurgery. 41: 798-805; discussion . PMID 9316040 DOI: 10.1097/00006123-199710000-00006  0.6
Show low-probability matches.